Press Release

Press Releases

Prominent Orthodontists Report Improved Predictability of Clinical Outcomes When Using AcceleDent in Conjunction with Aligners

HOUSTON (Sept. 22, 2016) – Orthodontists across Europe who have integrated AcceleDent® into their aligner treatment protocols report improved predictability of clinical outcomes resulting in a superior orthodontic experience. AcceleDent employs patented SoftPulse Technology® that more efficiently and effectively translates

OrthoAccel Receives Program Approval for Continuing Education (PACE) by Academy of General Dentistry

HOUSTON (Aug. 31, 2016) – The leader in accelerated orthodontics, OrthoAccel® Technologies, Inc., today announced it has received a Program Approval for Continuing Education (PACE) designation by the Academy of General Dentistry (AGD). According to the AGD, PACE was established

Orthodontists Report that AcceleDent Improves Predictability of Clinical Outcomes with Aligner Therapy

HOUSTON (August 1, 2016) – Highly regarded orthodontists in the U.S. report improved predictability of clinical outcomes when treating aligner patients with AcceleDent®, the first and only FDA-cleared vibratory device that has been clinically proven to speed up braces and

OrthoAccel Granted 3 New Patents –2 in the U.S. and 1 in China– for Proprietary Vibratory Orthodontic Technology Used in AcceleDent

HOUSTON (May 25, 2016) – OrthoAccel® Technologies, Inc., the leader in accelerated orthodontics, announced today that it has been granted two new patents from the United States Patent and Trademark Office, and one international patent from the State Intellectual Patent

AcceleDent® – The First and Only FDA-Cleared Vibratory Orthodontic Device

Clinical evidence shows that AcceleDent® speeds up orthodontic treatment by as much as 50 percent and relieves discomfort  HOUSTON – The first and only FDA-cleared vibratory orthodontic device, AcceleDent® is now available in more than 3,000 practice locations in North

OrthoAccel Announces $12 Million Series C Financing and New Investor, Piper Jaffray Merchant Banking

HOUSTON – (May 4, 2016) – OrthoAccel® Technologies, Inc. today announced completion of a $12 million Series C financing round, which included the privately held company’s two existing institutional equity investors, S3 Ventures and HealthpointCapital, as well as a new